nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjunctive anticoagulation during peripheral vascular intervention
|
Donovan, Robert J. |
|
2016 |
172 |
C |
p. 106-114 9 p. |
artikel |
2 |
Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial
|
Liu, Yong |
|
2016 |
172 |
C |
p. 88-95 8 p. |
artikel |
3 |
Automatic external defibrillator–only resuscitation in cardiac arrest? The approach may be shocking!
|
Olshansky, Brian |
|
2016 |
172 |
C |
p. 182-184 3 p. |
artikel |
4 |
Cerebrovascular accidents after percutaneous coronary interventions from 2002 to 2014: Incidence, outcomes, and associated variables
|
Didier, Romain |
|
2016 |
172 |
C |
p. 80-87 8 p. |
artikel |
5 |
Community-based automated external defibrillator only resuscitation for out-of-hospital cardiac arrest patients
|
Capucci, Alessandro |
|
2016 |
172 |
C |
p. 192-200 9 p. |
artikel |
6 |
Computer-guided normal-low versus normal-high potassium control after cardiac surgery: No impact on atrial fibrillation or atrial flutter
|
Hoekstra, Miriam |
|
2016 |
172 |
C |
p. 45-52 8 p. |
artikel |
7 |
Corrigendum to “Heart failure in low- and middle-income countries: Background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF)” (Am Heart J. 2015;170[4]:627-634)
|
Dokainish, Hisham |
|
2016 |
172 |
C |
p. 201- 1 p. |
artikel |
8 |
Design and rationale of the HITTS randomized controlled trial: Effect of High-intensity Interval Training in de novo Heart Transplant Recipients in Scandinavia
|
Nytrøen, Kari |
|
2016 |
172 |
C |
p. 96-105 10 p. |
artikel |
9 |
Editorial Board
|
|
|
2016 |
172 |
C |
p. A4- 1 p. |
artikel |
10 |
Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48 (ENGAGE AF–TIMI 48) trial
|
Eisen, Alon |
|
2016 |
172 |
C |
p. 144-151 8 p. |
artikel |
11 |
Employment and residential characteristics in relation to automated external defibrillator locations
|
Griffis, Heather M. |
|
2016 |
172 |
C |
p. 185-191 7 p. |
artikel |
12 |
Evaluation of a provocative dyspnea severity score in acute heart failure
|
AbouEzzeddine, Omar F. |
|
2016 |
172 |
C |
p. 34-41 8 p. |
artikel |
13 |
Excess weight and life expectancy after acute myocardial infarction: The obesity paradox reexamined
|
Bucholz, Emily M. |
|
2016 |
172 |
C |
p. 173-181 9 p. |
artikel |
14 |
Impact of standardized MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke (MonDAFIS): Rationale and design of a prospective randomized multicenter study
|
Haeusler, Karl Georg |
|
2016 |
172 |
C |
p. 19-25 7 p. |
artikel |
15 |
Information for Readers
|
|
|
2016 |
172 |
C |
p. A5- 1 p. |
artikel |
16 |
Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial
|
Thiele, Holger |
|
2016 |
172 |
C |
p. 160-169 10 p. |
artikel |
17 |
Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction
|
Wang, Tracy Y. |
|
2016 |
172 |
C |
p. 9-18 10 p. |
artikel |
18 |
Non-eligibility for reperfusion therapy in patients presenting with ST-segment elevation myocardial infarction: Contemporary insights from the National Cardiovascular Data Registry (NCDR)
|
Dasari, Tarun W. |
|
2016 |
172 |
C |
p. 1-8 8 p. |
artikel |
19 |
Novel mechanisms for cerebral blood flow regulation in patients with congenital heart disease
|
Saiki, Hirofumi |
|
2016 |
172 |
C |
p. 152-159 8 p. |
artikel |
20 |
Practice gaps in the care of mitral valve regurgitation: Insights from the American College of Cardiology mitral regurgitation gap analysis and advisory panel
|
Wang, Andrew |
|
2016 |
172 |
C |
p. 70-79 10 p. |
artikel |
21 |
Reducing cardiovascular risk through treatment of obstructive sleep apnea: 2 methodological approaches
|
Yaggi, Henry Klar |
|
2016 |
172 |
C |
p. 135-143 9 p. |
artikel |
22 |
Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects?
|
Pesaro, Antonio Eduardo P. |
|
2016 |
172 |
C |
p. 42-44 3 p. |
artikel |
23 |
Supporting open access to clinical trial data for researchers: The Duke Clinical Research Institute–Bristol-Myers Squibb Supporting Open Access to Researchers Initiative
|
Pencina, Michael J. |
|
2016 |
172 |
C |
p. 64-69 6 p. |
artikel |
24 |
Table of Contents
|
|
|
2016 |
172 |
C |
p. A1-A3 nvt p. |
artikel |
25 |
The role of diabetes mellitus in the composition of coronary thrombi in patients presenting with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
|
Sebben, Juliana C. |
|
2016 |
172 |
C |
p. 26-33 8 p. |
artikel |
26 |
Thrombus aspiration in patients with large anterior myocardial infarction
|
Calais, Fredrik |
|
2016 |
172 |
C |
p. 129-134 6 p. |
artikel |
27 |
Trends in hospitalization for takotsubo cardiomyopathy in the United States
|
Khera, Rohan |
|
2016 |
172 |
C |
p. 53-63 11 p. |
artikel |
28 |
Untangling the paradox: Obesity as prognostic marker in prevalent cardiovascular disease
|
O'Brien, Emily C. |
|
2016 |
172 |
C |
p. 170-172 3 p. |
artikel |
29 |
Utility of the Framingham Risk Score in predicting secondary events in patients following percutaneous coronary intervention: A time-trend analysis
|
Sara, Jaskanwal D.S. |
|
2016 |
172 |
C |
p. 115-128 14 p. |
artikel |